BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 06, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Sumavel DosePro sumatriptan regulatory update

Zogenix said the Danish Medicines Agency approved an MAA from partner Desitin for Sumavel DosePro sumatriptan injection to treat acute migraine with or without aura, and to treat cluster headache. The approval is...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >